European Digital PCR and Real Time PCR (qPCR) Market

European Digital PCR and Real Time PCR Market Size (2024 to 2029) 

Polymerase Chain Reaction (PCR) is an analytical process very extensively used in Molecular Biology to make multiple copies of a DNA segments. PCR can generate millions of copy from one DNA segment.

The European Digital PCR and Real Time PCR (qPCR) market accounted for USD 1.367 million in 2023. It is expected to grow at a rate of 8.964% and is predicted to around USD 2.29 billion in 2023. In recent years the increasing demand for fast diagnostics, decrepit population, infectious and genetic disorders such as cancer, HIV, Hepatitis are some of pushing factors for the market growth. Rapid technological advancements are also one reason that has recently attracted investments in the market, but still, a lot of growth is expected in this market.  However, technical glitches and high initial cost of the dPCR & qPCR is a pulling force for the market. 

European Digital PCR and Real Time PCR Market Segmentation

Market is segmented by Product, by Technology, by Application, by End User & by Region. By Product the market is segregated into Consumables & Reagents, Instruments. By Technology the market is segregated as Quantitative PCR and Digital PCR. By Application the market is categorized as Tumors, Blood Testing, Pathogen Detection, research & forensics. By End User it is categorized as Hospitals, Research & Forensic centers, Pharmaceuticals & Bio- Technological Firms, Academic Intitutions. By geography the market is segmented into Germany, France, Italy, Spain, & U.K.

Recent Development

Recently, HDPCR multiplexing technology has been developed that combine’s proprietary data science algorithms that enrich the multiplex levels of common real time and digital PCR for detection of 5-50 target sites in a reaction at low cost. A profusion of bacterial allosteric transcription factors (sTF) have been discovered to study about variety of very small molecules. A TF based nicked DNA segment-assisted signal transduction system (a TF-NAST) is used.

The major key players in the market are Thermo Fisher Scientific Inc., F Hoffman-La Roche Ltd., Bio-Rad Laboratories, Qiagen N.V., Taraka Bio Inc., Affymetrix Inc., Agilent Technologies Inc., Fluidigm Corporation, Danaher Corporation, and Becton & Dickson Company.